Assignee
DISC MEDICINE INC
US·4 granted patents·20 pending applications·1 citations·filing 2019–2025
Top patents by PatentIndex Score
24 records- 0190US12365729B2Anti-hemojuvelin (HJV) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2024·Granted Jul 22, 2025·1 cites·30 claims
- 0287US2026055181A1Anti-hemojuvelin (hjv) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2025·Application pending·0 cites
- 0387US2026098088A1Anti-hemojuvelin (hjv) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2025·Application pending·0 cites
- 0481US12497452B2Anti-hemojuvelin (HJV) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2025·Granted Dec 16, 2025·0 cites·28 claims
- 0579US2026049131A1Anti-hemojuvelin (hjv) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2025·Application pending·0 cites
- 0673US2025248995A1Compositions and methods for treating polycythemiaDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 0771US2023174645A1Anti-hemojuvelin (hjv) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2021·Application pending·0 cites
- 0871US2024269132A1Compositions and methods for treating polycythemiaDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 0971US2025262204A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 1064US2024400553A1Amine based matriptase 2 inhibitors and uses thereofDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 1163US11813257B2Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2021·Granted Nov 14, 2023·0 cites·23 claims
- 1262US2024366574A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 1362US2026027107A1Compositions and methods for treating polycythemiaDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 1459US2024417458A1Methods for treating anemia of kidney diseaseDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 1558US2025228827A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsDISC MEDICINE INC·Filed 2025·Application pending·0 cites
- 1656US2025302823A1Compositions and methods for treating hepatic porphyrias with glycine transport inhibitorsDISC MEDICINE INC·Filed 2023·Application pending·0 cites
- 1755US2025312445A1Methods for treating blood loss conditionsDISC MEDICINE INC·Filed 2023·Application pending·0 cites
- 1854US2024390362A1Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with a solid form of bitopertinDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 1953US2024325382A1Compositions and methods for treating anemia associated with a ribosomal disorderDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 2052US2024317801A1Peptidomimetic matriptase 2 inhibitors and uses thereofDISC MEDICINE INC·Filed 2021·Application pending·0 cites
- 2151US2023183339A1Anti-hemojuvelin (hjv) antibodies for treating anemia of chronic diseaseDISC MEDICINE INC·Filed 2021·Application pending·0 cites
- 2247US2022372135A1Methods for treating myelofibrosis and related conditionsDISC MEDICINE INC·Filed 2020·Application pending·0 cites
- 2346US2022372136A1Methods for treating anemia of chronic diseaseDISC MEDICINE INC·Filed 2020·Application pending·0 cites
- 2440US12428415B2Matriptase 2 inhibitors and uses thereofDISC MEDICINE INC·Filed 2019·Granted Sep 30, 2025·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when DISC MEDICINE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →